テネシーにおける頭頸部扁平上皮癌の臨床試験
テネシー内の拠点で、頭頸部扁平上皮癌に関する43件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site#0126, Nashville
- Site #0116, Nashville
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06788990A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #3, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Tennessee Cancer Specialists, Knoxville
- Vanderbilt University Medical Center, Nashville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07276399Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Vanderbilt University Medical Center, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第2相
18歳〜79歳 · 全性別 · 2026/09/22更新 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Sarah Cannon - Tennessee Oncology, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sarah Cannon Research Institute, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Sarah Cannon Nashville, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Sarah Cannon and HCA Research Institute, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07462377A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Vanderbilt University, Nashville
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/03更新 · NCT06163534A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- University of Tennessee Medical Center, Knoxville
- Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06769698A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Methodist Hospital, Memphis
- University of Tennessee Health Science Center, Memphis
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- University of Tennessee - Knoxville, Knoxville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06532279SMP-3124LP in Adults With Advanced Solid Tumors
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06526819A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Erlanger Health, Inc, Chattanooga
- The West Clinic, Germantown
- SCRI Oncology Partners, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
- Vanderbilt University Medical Center, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT06819228A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- The University Of Tennessee Health Science Center, Memphis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Tennessee Oncology, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06150664First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- The West Clinic, PLLC dba West Cancer Center, Germantown
- Sarah Cannon Research Institute, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
- Vanderbilt University Medical Center, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07460765A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- US Oncology Research LLC, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- SCRI Oncology Partners, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07503808A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Chattanooga
- GSK Investigational Site, Germantown
- GSK Investigational Site, Nashville
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/26更新 · NCT06256588Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
- Vanderbilt University Medical Center, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/11更新 · NCT07217028High-Resolution PET-CT Imaging for Surgical Margin Visualization
- Vanderbilt University Medical Center, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/05/08更新 · NCT06915454(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第1相
19歳以上 · 全性別 · 2026/05/08更新 · NCT05747625Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/05/06更新 · NCT07555210A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Tennessee Oncology, PLLC, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/06更新 · NCT05785741Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第1相
19歳以上 · 全性別 · 2026/03/05更新 · NCT05901545A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 136, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Nashville
- Veterans Affairs Medical Center - Nashville, Nashville
- 他1件
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2025/10/28更新 · NCT00898638Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第1相
19歳以上 · 全性別 · 2025/10/03更新 · NCT05945875A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Tennessee Oncology, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/24更新 · NCT05941507Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2025/08/15更新 · NCT04429542ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。